Cases 41 - 50 of 262
CELGENE CORPORATION v. MYLAN PHARMACEUTICALS INC. et al
as 2:2019cv05802
Plaintiff:
CELGENE CORPORATION
Defendant:
MYLAN PHARMACEUTICALS INC., MYLAN INC. and MYLAN N.V.
Cause Of Action: 15 U.S.C. § 1126
HORIZON PHARMA, INC., ET AL. V. DR. REDDY'S LABORATORIES, INC., ET AL.
as 2:2017cv11635
Petitioner:
BAKER BOTTS LLP and PHV STEPHEN M. HASH
Defendant:
LUPIN LTD, MYLAN PHARMACEUTICALS INC., MYLAN LABORATORIES LIMITED and others
Plaintiff:
HORIZON PHARMA, INC and POZEN INC.
Cause Of Action: Motion to Quash
Anacor Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. et al
as 1:2018cv01699
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Plaintiff:
Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Anacor Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. et al
as 1:2018cv00202
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Plaintiff:
Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
AstraZeneca AB et al v. Mylan Pharmaceuticals Inc. et al
as 1:2018cv01562
Plaintiff:
AstraZeneca Pharmaceuticals LP and AstraZeneca AB
Defendant:
Mylan Inc., Mylan N.V., Mylan Laboratories Limited and others
Cause Of Action: 35 U.S.C. § 271
CELGENE CORPORATION v. MYLAN PHARMACEUTICALS INC. et al
as 2:2018cv16035
Plaintiff:
CELGENE CORPORATION
Defendant:
MYLAN PHARMACEUTICALS INC., MYLAN INC. and MYLAN N.V.
Cause Of Action: 15 U.S.C. § 1126
Valeant Pharmaceuticals North America LLC et al v. Mylan Pharmaceuticals Inc. et al
as 1:2018cv00184
Plaintiff:
Kaken Pharmaceutical Co. Ltd., Dow Pharmaceutical Sciences, Inc., Valeant Pharmaceuticals North America LLC and others
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Ltd.
Cause Of Action: 35 U.S.C. § 271
AstraZeneca AB et al v. Mylan Pharmaceuticals Inc. et al
as 1:2018cv00193
Plaintiff:
Astrazeneca Pharmaceuticals LP and AstraZeneca AB
Defendant:
Mylan Inc., Mylan N.V., Mylan Laboratories Limited and others
Cause Of Action: 35 U.S.C. § 271
VALEANT PHARMACEUTICALS NORTH AMERICA LLC et al v. MYLAN PHARMACEUTICALS INC. et al
as 3:2018cv14305
Plaintiff:
KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS NORTH AMERICA LLC and others
Defendant:
MYLAN PHARMACEUTICALS INC., MYLAN INC. and MYLAN LABORATORIES LTD.
Cause Of Action: 35 U.S.C. § 271
MYLAN TECHNOLOGIES, INC. et al v. NOVARTIS PHARMACEUTICALS CORPORATION
as 2:2018cv12022
Plaintiff:
MYLAN N.V., MYLAN TECHNOLOGIES, INC., MYLAN PHARMACEUTICALS INC. and others
Defendant:
NOVARTIS PHARMACEUTICALS CORPORATION
Cause Of Action: Motion to Compel
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
